Comparing methods for targeting radiation therapy in spinal tumors

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to compare the efficacy and side effects of two different methods for delineating target volumes in stereotactic radiotherapy for metastatic spinal tumors. Approximately 500 patients will be enrolled and divided into two groups based on the target delineation method used: one group will focus solely on the local tumor, while the other will include both the local tumor and the adjacent vertebral area. The study is observational and will assess outcomes based on imaging data and patient follow-up after treatment.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patients with spinal metastases or primary tumors receiving stereotactic radiotherapy;
* Patients with sufficent pre-treatment imaging data
* Patients who can cooperate with imaging review and follow-up after radiotherapy.

Exclusion Criteria:

* Patients with an expected survival of less than 3 months;
* Patients with second-course radiotherapy;
* Patients with physical conditions that cannot tolerate stereotactic radiotherapy;
* Patients with extensive spinal metastasis and no local therapeutic value

Where it's running

• Department of Radiation Oncology Cancer Center, Peking University Third Hospital 49# North Garden Rd.,Haidian Dist.
  Beijing, Beijing Municipality, China Recruiting

Study contacts

• Study coordinator: Hongqing Zhuang, Doctor
• Email: hongqingzhuang@163.com
• Phone: 13051776232

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Heart-friendly medicines to protect chest-area cancer patients from radiation damage

  This Phase 2 trial tests whether taking atorvastatin and lisinopril can reduce heart damage in adults with chest-area cancers who receive radiation therapy.

  Recruiting Phase 2 UNC Lineberger Comprehensive Cancer Center · Chapel Hill, North Carolina · NCT07685938

• Radiotherapy after Separation Surgery for Spinal Metastases

  This study tests whether giving radiotherapy after separation surgery helps people with spinal metastases live longer and feel better.

  Recruiting Shanghai Changzheng Hospital · Shanghai, Shanghai Municipality · NCT07527884

• Comparing surgery followed by radiation to radiation alone for spinal tumors

  This study is testing whether surgery followed by radiation or radiation alone is better for helping people with spinal tumors keep their ability to walk three months after treatment.

  Recruiting at 3 sites Cancer Research Antwerp · Aalst and 8 other locations · NCT06613295

• Treatment of high-grade glioma in young patients using olutasidenib and temozolomide

  This study is testing if a new combination of olutasidenib and temozolomide can help young patients with high-grade gliomas that have a specific mutation feel better after their radiotherapy.

  Recruiting at 8 sites Phase 2 Rigel Pharmaceuticals · Aurora, Colorado and 19 other locations · NCT06161974

• Comparing two surgical approaches for spinal oligometastatic tumors with radiotherapy

  This study is testing whether two different types of surgery combined with radiation can help people with spinal cancer live longer and feel better.

  Recruiting Shanghai Changzheng Hospital · Shanghai, Shanghai Municipality · NCT06120426

• Monitoring the safety and performance of Ennovate® Cervical implants

  This study is looking at how safe and effective the Ennovate® Cervical implants are for patients with different spinal problems like fractures and disc disease.

  Recruiting Aesculap AG · Hamburg, Free and Hanseatic City of Hamburg and 3 other locations · NCT05296889

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.